Podcasts about healthtech

Healthcare companies are built to improve patients' lives. So why do so many prioritize shareholders over the people they're meant to serve?This week, Halle sits down with Eric Ries, author of Incorruptible, to unpack the rise of shareholder primacy, what it is, and why he believes it's at the root of many of society's biggest challenges. They discuss the surprising history of corporate governance, the lessons behind Novo Nordisk's century-long success, and what founders can do today to keep their companies aligned with their mission as they grow.We cover:Why shareholder primacy reshaped corporate America (and where we go from here)How Novo Nordisk's unusual ownership structure may have saved GLP-1 researchThe simple governance change that could preserve your company's mission for decadesHow boards, investors, and acquisitions can slowly pull companies away from their original purposeThe founder mistakes that make mission drift almost inevitableAbout our guest:Over the last two decades, Eric Ries's ideas about continuous innovation, long-term thinking, governance, and market reform have reshaped company building and management practices. He is the creator of the Lean Startup method, and the author of two New York Times bestsellers The Lean Startup and Incorruptible; The Leader's Guide; and The Startup Way. As a founder, he has put his own ideas into practice with The Long-Term Stock Exchange (LTSE); Answer.AI, an AI R&D lab; Virgil, a legal services startup; and IMVU. On The Eric Ries Show, he talks with world-class technologists, thought leaders, and executives building for the long-term. Check out his book, Incorruptible: Why Good Companies Go Bad…and How Great Companies Stay Great—

The State of Healthtech Marketing – Mid-Year Check-in Over the last month, host Adam Turinas has spoken with more than 30 health tech marketing leaders who are part of the Healthtech Marketing Network. He wanted to hear firsthand from them about how the first half of the year has gone and how they're feeling about the rest of 2026. He was surprised by what I heard. On this episode, he sits down with his colleague Mark Erwich, Chief Strategy Officer at Health Launchpad, to discuss what they learned. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

This week on Pulse: Hot Topics, Louise and George look at what happens when digital health stops being a pilot and starts being a system decision — and why, again and again, the technology isn't the hard part.Portugal Buys AI Physiotherapy for an Entire Country — Portugal's National Health Service has contracted Sword Health to make AI-supported physiotherapy available to all 10 million citizens, free after a prescription, prompting the question: are governments shifting from buying AI software to buying AI-delivered healthcare?AI and Accountability: The First Complaints Land — The UK's first complaints about clinicians' inappropriate use of AI have reached professional regulators, arriving well before the evidence base and accountability frameworks are ready.95% of Health Apps Have No Verifiable Regulatory Approval — Rudolf Wagner's analysis found that of nearly 96,000 apps qualifying as Software as a Medical Device, 95% had no verifiable CE marking or FDA authorisation, leaving consumers with no easy way to know what they're actually using.Doctors Want Wearable Data, But Can't Use It — A new AMA(US) survey found 97% of physicians would review data from a patient's wearable, but no more than 6% have actually integrated it, blocked by missing standards, workflow fit, reimbursement and liability.Virtual Care Could Transform Residential Aged Care — Australian researchers found virtual care between aged care homes and GPs improves access and reduces unnecessary hospital visits, but is undermined by poor integration, unreliable networks and limited staff training — the technology works, the system around it doesn't.With Thanks to Datacom:Download the Executive Briefing Playbook LinkResources:Sword Health partners with Portugal's National Health Service LinkFirst complaints made over clinician use of AI, HSJ via Patient Safety Learning Hub LinkEnsuring the clinical impact of medical artificial intelligence, Andreoletti et al., Lancet Digital HealthLinkAnalysis of Software as a Medical Device (SaMD) Compliance in App Store Applications, Rudolf Wagner LinkDocs unable to harness wearables data, survey finds, Axios LinkVirtual care could benefit residential homes – study, Pulse+IT LinkVirtual care in residential aged care homes, Journal of Medical Internet ResearchLinkRecommendations:Clinicians – be part of the research into clinician use of AI, open globally LinkStandards Australia telehealth and virtual care standard LinkThere's An AI For That (TAAFT) newsletter LinkAge-Friendly Futures newsletter, George Gouzounis Link"Welcome to the Land of the Free" — World Cup song by Jason Stills LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Episode 80 - Tom Whicher is CEO and Co-founder of DrDoctor. He co-founded the company after seeing patients struggle with hospital appointments and has since expanded it across NHS trusts, improving care and patient engagement.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Over the last decade, the number of drug candidates entering development has doubled, yet the number of successful drug approvals remains flat at ~50 per year.This week, we sit down with Formation Bio founder and CEO Ben Liu. His company has raised more than $600 million to build what he hopes will become the first new enduring pharmaceutical company in decades, powered by AI. Ben explains why he believes clinical development, not drug discovery, is becoming the industry's biggest bottleneck, and how AI could fundamentally change the economics of bringing new medicines to patients.We cover:Why there hasn't there been a big pharma company created since the 1980sWhich drug categories Ben believes could become the next GLP-1s and reshape healthcareWhy Formation Bio chose to become a pharmaceutical company instead of selling softwareThe real bottleneck in bringing medicines to patientsBen's roadmap for how AI will transform drug development over the next 10 to 20 yearsAbout our guest:Ben Liu is the co-founder and CEO of Formation Bio. He received his DPhil at Oxford as a Rhodes Scholar, leveraging machine-learning, AI, and big-data to develop diagnostics and therapeutics for Parkinson's and Alzheimer's disease. During his graduate work, he observed the way clinical trials bottlenecked the development of new treatments for patients, compelling him to start Formation Bio.Before Formation Bio, Ben graduated from Yale where he was awarded the college's highest honor at graduation and received his MPhil with distinction in Computational Biology from the Department of Applied Mathematics and Theoretical Physics at Cambridge as a Paul Mellon Fellow. Ben also serves as an Advisor to Harvard Business School's MS/MBA Program in Biotechnology.—

How Peer-Reviewed Evidence Drives AI Discoverability If a potential buyer asked an AI chatbot which companies are leading in your space, would your company come up? And if it did, would the answer be positive? On this episode, host Adam Turinas sits down with Paul Wicks, Founder and Chief Evidence Officer of ProofStack Health, and colleague Mark Erwich, Chief Strategy Officer of Health Launchpad, to dig into an underappreciated aspect of B2B health tech: the power of hard evidence.

This week on Pulse: Amplify, Louise and George sit down with patient advocate and AI Champion, Hugo Campos.Hugo Campos has spent nearly two decades fighting for a simple principle: patients should have access to the data generated by their own bodies. After discovering that his implanted cardiac defibrillator was sending information to clinicians and manufacturers—but not to him—he became one of the world's leading advocates for patient data rights.In this episode, Hugo explains why generative AI changes everything. Rather than waiting for hospitals or vendors to build better tools, patients can now create their own AI-powered applications, analyse their own health data and ask questions that matter to them.We discuss patient-directed AI, the rise of personalised "N-of-1" healthcare, critical AI health literacy, and why the next wave of healthcare innovation may come from patients themselves—not institutions.Connect with Hugo on LinkedInResources – open source, freely available by Hugo:https://caihl.org/ (framework of critical ai health literacy)https://openkp.org/ (mcp server for access to provider data)https://myheartdata.org/ (19 years of Hugo's own echo data)https://hugotronic.com/ (longitudinal data from Hugo's implantable defibrillator)https://endothelial.org/ (explains endothelial dysfunction, built for Dave)Hugo's newest app:https://hugoscore.org/ (evaluates patient-facing health apps throught he CAIHL lens)Visit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

I veckans avsnitt träffar vi Helén Styffe, grundare av Hlessbeauty och entreprenör inom HealthTech, BeautyTech och longevity. Helén arbetar med hälsa, hudvård och välmående ur ett helhetsperspektiv – där teknik, data, näring och livsstil möts. Det blir ett samtal om wellaging, biohacking, cellhälsa och vad skönhet egentligen betyder när man börjar se kroppen inifrån och ut. Helén: https://linktr.ee/hlessbeauty

They built a $1.2 billion healthcare AI company in under three years, but they say the hardest part of healthcare AI isn't the AI.This week, Halle sits down with Assort Health co-founders and co-CEOs Jeffery Liu and Jon Wang, whose company reached a $1.2 billion valuation in under three years. They discuss why building great healthcare AI takes far more than good models, how they scaled from 15 employees to nearly 250 in a year, and what they've learned from more than 190 million patient interactions. They also share why voice AI is harder than it looks, how they're thinking about building durable moats in the age of foundation models, and why helping patients navigate the healthcare system may be one of AI's biggest opportunities.We cover:The AI role suddenly showing up at every healthcare startupThe surprising demographic that gives AI voice agents the highest satisfaction scoresHow healthcare AI is shifting from single-purpose tools to platforms that remember patients across every interactionWhy the biggest moat in healthcare AI may not be the model itselfThe biggest misconception investors have about moats in healthcare AIHow to triple your team without losing the culture that made the company successful—

In this episode of Medsider Radio, we sat down with Dr. Sudhir Srivastava, founder, chairman, and CEO of SS Innovations (Nasdaq: SSII). The company's SSi Mantra surgical robotic system supports a variety of surgical robotic procedures, including cardiac surgery. Sudhir brings more than three decades of experience in minimally invasive and robotic cardiac interventions, having served as Director of Robotic Cardiac Surgery at the University of Chicago and founder of the International College of Robotic Surgery. A pioneer in the field, Sudhir has performed more than 1,400 robotic procedures, including over 750 beating-heart totally endoscopic coronary artery bypass (TECAB) surgeries.In this interview, Sudhir discusses what it takes to democratize robotic surgery beyond affordability, how SS Innovations built teleproctoring, telesurgery, and the supporting infrastructure for its robotic platform, and his milestone-based approach to financing a capital-intensive medtech company. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Sudhir Srivastava, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:01) - Sudhir's journey from performing the world's first beating-heart robotic bypass to founding SS Innovations (07:14) - The 22-year-old patient who became the catalyst for Sudhir's affordable robotic surgery platform (08:59) - Building Mantra 3 from the ground up in just five months (12:14) - Inside the engineering process that eliminated months of costly iteration (16:20) - The question that shaped SS Innovations: "How do you democratize access?" (27:10) - From one office to performing 24 telesurgeries in 12 hours across India (29:29) - How a mobile training bus became part of Sudhir's answer to make robotic surgery accessible (33:49) - Lessons from commercializing a surgical robotics platform across developing markets (39:43) - Starting with just $5 million: Sudhir's milestone-based approach to fundraising

Nederland kan jaarlijks ruim 350.000 ziekenhuisopnames en bijna 500.000 consulten voorkomen door patiënten thuis te volgen in plaats van in het ziekenhuis. De technologie is er, werkt en groeit hard, maar de brede opschaling komt moeizaam van de grond. De grootste obstakels zitten niet in de zorg zelf, maar in de manier waarop die wordt bekostigd en in de versnipperde uitwisseling van patiëntgegevens. In deze aflevering van BNR Beter bespreekt Nina van den Dungen de opkomst van thuismonitoring en de virtuele verpleegafdeling. Te gast zijn Michael van Herwerden, internist-intensivist bij het Erasmus MC en initiatiefnemer van de virtuele verpleegafdeling, en Jan Willem Spijkman, sectorbankier gezondheidszorg bij ING en medeauteur van een themastudie over thuismonitoring in ziekenhuizen. Van Herwerden legt uit hoe de virtuele verpleegafdeling werkt: de diagnose wordt in het ziekenhuis gesteld, maar het herstel verplaatst naar de huiskamer. Patiënten meten thuis een paar keer per dag zelf hun bloeddruk en zuurstofgehalte en vullen een vragenlijst in; een gespecialiseerde telenurse beoordeelt die waarden binnen het uur en schakelt bij afwijkingen de behandelend arts in. Bloedafname loopt via een regionale prikdienst, en zelfs een infuus met antibiotica kan thuis, met hulp van een technisch thuisteam. Het Erasmus MC blijft medisch verantwoordelijk alsof de patiënt is opgenomen. Zorgpaden voor onder meer hypofyse-operaties, bacteriële infecties en hartfalen laten zien wat al kan en waar de grenzen liggen, bijvoorbeeld bij medicijnen met een nauwe marge. Spijkman schetst de urgentie: het personeelstekort loopt op van zo'n 70.000 vacatures nu naar ruim 240.000 in 2034, terwijl de zorgvraag door vergrijzing en multimorbiditeit blijft groeien. Ongeveer de helft van de ziekenhuiszorg zou thuis kunnen plaatsvinden. Toch remt de bekostiging de opschaling af: een patiënt die naar het ziekenhuis komt, levert via de diagnose-behandelcombinaties meer op dan een belletje of een meting op afstand. Volgens Spijkman ligt de sleutel bij afspraken tussen ziekenhuizen en zorgverzekeraars, zoals een aanneemsom voor complexe zorg, zodat ziekenhuizen ruimte krijgen om zorg thuis op te schalen. Transitiegelden uit het Integraal Zorgakkoord en de komende doorbraakmiddelen van VWS moeten die verschuiving verder aanjagen. Ook de uitwisseling van patiëntgegevens komt aan bod. Nederland koos ooit tegen een landelijk EPD, wat volgens Van Herwerden een grote misser was. Waar België en Finland met systemen als Kanta vooroplopen, werken initiatieven als Digizorg, Zorgviewer en CumuluZ hier nog aan een landelijk dekkend netwerk, met de Europese EHDS-verordening in 2031 als stok achter de deur. Over deze podcast BNR Beter is het wekelijkse programma van BNR Nieuwsradio over een toekomstbestendige zorgsector. Elke week bespreekt presentator Nina van den Dungen met zorgprofessionals, ondernemers en beleidsmakers hoe de Nederlandse zorg met technologie, innovatie, regelgeving en wetenschap beter kan worden. BNR Beter is elke maandag om 15:30 op de radio te beluisteren bij BNR Nieuwsradio, en vanaf dat moment ook als podcast via deze feed. Over de makers Nina van den Dungen (1987) is freelance journalist en als radio- en podcastpresentator al ruim 15 jaar verbonden aan BNR. Zo is ze regelmatig te horen als presentator van de nieuwsprogramma's in de ochtend- en avondspits en daarnaast presenteert ze wekelijks de beleggingspodcast Doorgelicht en BNR Beter over de zorgsector. Stijn Goossens (1996) is de redacteur van BNR Beter en plaatsvervangend presentator. Bij BNR houdt Stijn zich bezig met onderwerpen over tech, wetenschap en innovatie. Hij presenteert ook de podcast Op de zaak en test elke vrijdag een nieuw techproduct in de Ochtendspits op BNR. Hiervoor was Stijn werkzaam voor NTR Wetenschap en techplatform Bright.See omnystudio.com/listener for privacy information.

Send us Fan MailCan artificial intelligence really think like a physician - or is it simply predicting words?This week we're joined by Dr. Michal Tzuchman-Katz, MD, physician, AI entrepreneur, pediatrician, and Chief Innovation & Research Officer at Maccabi Healthcare, one of the world's most advanced healthcare organizations. We explore why the future of medicine isn't just better AI - it's building healthcare systems that learn from every patient.Dr. Michal Tzuchman-Katz, MD is a physician, technologist, entrepreneur, and healthcare innovation leader who currently serves as Chief Innovation & Research Officer at Maccabi Healthcare Services ( https://www.maccabi4u.co.il/ ), one of Israel's largest and most advanced healthcare organizations.What makes Dr. Tzuchman-Katz's story extraordinary is that she has worked across nearly every layer of modern health technology. She began her career as a software engineer, earned her medical degree with honors, trained as a pediatrician, studied genomics and biomedical informatics, and went on to co-found and lead Kahun, an AI-powered clinical reasoning company that developed a knowledge-graph engine containing more than 30 million evidence-based medical insights.At Kahun, Dr. Tzuchman-Katz became a pioneer in explainable AI for physicians, focusing on making AI-generated recommendations transparent, traceable to medical evidence, and aligned with the way clinicians actually think. Today, at Maccabi, Dr. Tzuchman-Katz oversees innovation and research initiatives that leverage one of the world's richest longitudinal healthcare datasets and biobanks to develop and scale technologies that can improve patient outcomes at population level.Remarkably, while leading innovation for a major healthcare system, Dr. Tzuchman-Katz continues to practice as a pediatrician, giving her a uniquely grounded perspective on the promises and limitations of AI in real clinical care.#HealthcareInnovation #ArtificialIntelligence #MedicalAI #PrecisionMedicine #HealthTech #DigitalHealth #ClinicalAI #Medicine #Healthcare #Biotech #Genomics #Innovation #FutureOfMedicine #HealthcareData #MachineLearning #MedicalResearch #Pediatrics #PreventiveMedicine #PersonalizedMedicine #PPPSupport the show

The following article of the Health industry is: “Real-World Intelligence: The Key to Healthtech Equity in Mexico” by Hector Barillas, General Manager, Wiener Lab.

How to Build Pipeline With Podcasts One of the questions host Adam Turinas often hear most from healthtech marketers is whether starting a podcast is actually worth it. And if you already have one, are you thinking about it the right way? He brought on two guests who have built one of the most distinctive shows in healthtech together: Ed Gaudet, CEO and Founder of Censinet, and his brother Mark Gaudet, Director of Market Development at Censinet and the host of their podcast, Risk Never Sleeps, which just hit 200 episodes. This conversation gets past the usual “build your brand” rationale for podcasting and into the real, honest story of what it actually takes and what it actually delivers. Ed and Mark talk about the grind of those first six months, why most podcasts never make it past 25 episodes, and how Risk Never Sleeps has become a genuine source of pipeline for Censinet. Adam share his own experience too, including how syndication 5X'd our reach and how listeners have turned into real business conversations. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

This week on Pulse: Hot Topics, Louise reports in from a heatwave in the French Alps while George braces for a Sydney winter — before the pair work through five stories on a single throughline: AI adoption by clinicians and patients is racing ahead of the institutions meant to govern it.They discuss why more than half of UK GPs are now using generative AI in clinical practice, how an AI system analysing a routine ECG helped save a patient's life, the emergence of agentic AI capable of managing clinical workflows, a robotic platform accelerating cancer drug discovery, and an Australian-developed wearable "stethoscope sticker" designed to continuously monitor heart and lung sounds.Resources:Half of UK GPs Now Use AI Blease et al LinkAI Flagged a Failing Heart Hartman et al Nature LinkAgentic AI Comes to Medicine Topol, Ground Truths LinkAIME, Lievin et al Nature LinkMIRA, Ferber et al Nature LinkUpDoc FDA-clearance announcement — PRNewswire LinkShrestha, Innolitics LinkPersistern Cells, Sun et al., ScienceAdvances LinkThe "Stethoscope Sticker" Dang et al., LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Episode 79 - Julian co-founded Asterix Health in 2024 after his own experience with heart valve disease. At Asterix, he's tackling the shortage of qualified clinical staff with a model that's already supporting 250K patients across the UK.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

July marks five years of The Heart of Healthcare, and we're grateful for every listener who's tuned in. If you've enjoyed the show, please show your love by leaving us a review!This month, Steve and Halle take stock of an industry where capital is concentrating, incumbents are making big bets, AI is moving from promise to early proof points, and a public health crisis is quietly building in the background.We cover:The digital health funding numbers that just dropped, and what they reveal about where the money is really goingA $12 billion deal that has the RCM world buzzingThe Nature study that has clinical AI companies on edgeA new entrant into medical imaging that nobody saw comingThe public health crisis that sports betting built, and why healthcare isn't talking about it enoughEarly data out of Utah that could change how we think about AI in clinical settingsLinks:IPO Watch List: https://halletecco.substack.com/p/the-digital-health-ipo-watchlistEnsemble Health / Thoreau deal: https://hitconsultant.net/2026/06/18/thoreau-makes-strategic-investment-in-ensemble-health/Nature Medicine AI study: https://www.nature.com/articles/s41591-026-04431-5Midjourney Medical: https://www.theverge.com/ai-artificial-intelligence/952011/midjourney-medical-ai-ultrasound-scanDoctronic pilot outcomes: https://commerce.utah.gov/wp-content/uploads/2026/05/Doctronic-Outcomes-May-2026.pdf—

In this episode of Medsider Radio, we sat down with Aditya Rajagopal, co-founder and CEO of Esperto Medical.Esperto is a Caltech spin-out utilizing compressed sensing technology with ultrasound to continuously and non-invasively measure blood pressure.Before Esperto, Aditya co-founded ChromaCode, a molecular diagnostics company, and was a researcher at Google[x], where he worked on novel medical imaging methods. Aditya also serves as part-time faculty at Caltech and USC, and holds BS, MS, and PhD degrees in Electrical Engineering from Caltech. In this interview, Aditya discusses why great science doesn't necessarily make great companies, what it takes to win as a fast-follower in medtech, and how to sequence a platform technology without spreading resources too thin.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Aditya Rajagopal, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:44) - Aditya's journey from Caltech and Google to tackling one of medicine's hardest engineering problems at Esperto (05:17) - How Esperto is trying to solve a 50-year-old problem: continuous blood pressure monitoring without an arterial catheter (07:17) - Why Esperto was okay with being a fast-follower in an established market instead of creating a new one (16:12) - "Great science doesn't necessarily make great companies" and other lessons Aditya learned at ChromaCode (24:02) - Three hurdles every medical device must clear before clinicians will actually adopt it (27:44) - How Aditya determines whether a technical problem actually has a "there there" (37:51) - Esperto's pitch strategy and how it raised from a position of strength (43:18) - What first-time founders often misunderstand about how venture capital actually works

The Low Volume, High Intent Era: What AI Search Is Doing to Health Tech Buyer Behavior Something fundamental has changed in how health tech buyers do research, and if you're watching your website traffic decline, you might be misreading what it actually means. On this episode host Adam Turinas sits down with Suyog Deshpande, Founder and CEO of Webless AI, to dig into one of the most consequential shifts in B2B buyer behavior in a generation. Here's what's actually happening: your buyers haven't stopped doing research. They've moved it upstream — to ChatGPT, Claude, Perplexity, and Gemini. They're building their shortlists there, forming their preferences there, all before they ever land on your website. By the time they show up, they're not browsing. They're validating. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

On this week’s episode of the Disaster Podcast, we chat with Dr. Tehnaz Boyle. Dr. Boyle is a pediatric emergency physician and a scientist who studies how to use technology to bring expert care to disaster situations remotely. She works with Health Tech Without Borders who we talked about three years ago on the show related to their work during the early days of the Ukraine war. Previous Disaster Podcast Episode on Health Tech Without Borders Health Tech Without Borders is a global non-profit organization aiming to mitigate healthcare crises by leveraging digital tools and technology to provide immediate access to health resources. They work in disaster and war torn areas of the world to bring medical and health expertise. ASPR Telemedicine Program Site The episode was co-hosted by Sam Bradley and Jamie Davis and they were joined by Disaster Emergency Management expert Becky DePodwin. Scroll down for Podcast Discussion Summary Thank you as always to Paragon Medical Education Group for their long-term support of the Disaster Podcast. Dr. Joe Holley and the team at Paragon continue to provide excellent and customized disaster response training to jurisdictions around the U.S. and internationally as well. Podcast Discussion Summary Global Earthquake Response Discussion The team discussed recent earthquake events, including a 7.2 magnitude earthquake followed by a 7.5 magnitude earthquake in Venezuela, along with additional earthquakes in Northern California and Japan. Becky explained that the back-to-back high-magnitude quakes in Venezuela would likely worsen the already devastating impact, with many older structures built in the 1950s and 1960s failing to meet modern earthquake safety standards. The discussion highlighted that USAID’s traditional role in international disaster response is no longer available, creating a gap in global disaster relief efforts. The team planned to have a more detailed discussion about the Venezuela situation in next week’s episode, including updates on response efforts from organizations like Med Global and Health Tech Without Borders. Health Tech Without Borders Overview Tehnaz, an associate professor and pediatric emergency medicine physician at Boston Medical Center, explained Health Tech Without Borders, a nonprofit that uses digital tools to provide access to medical care during humanitarian emergencies. She described their work in Ukraine, where they partnered with local providers and international clinicians to deliver telehealth services to displaced populations. Tehnaz also discussed the organization’s role as an innovative hub connecting companies with medical experts, and highlighted the potential for AI and satellite communications to enhance their capabilities in providing remote care. Telehealth Applications and Remote Monitoring Tehnaz explained various telehealth applications including digital consultations, remote patient monitoring, and digital therapeutics, using examples from Ukraine and burn care centers in the US. She described how remote monitoring could allow patients to receive care at home instead of in long-term facilities, particularly benefiting those in healthcare deserts and rural areas. When asked about connected medical equipment, Tehnaz noted that while many devices can connect to networks, not all collected data is necessarily helpful or interpretable, requiring research to determine useful signals from noise. Telehealth in Crisis Response Tehnaz discussed Health Tech Without Borders’ work in providing telehealth services and training for clinicians in crisis areas, including Ukraine. She explained the challenges of licensing and governance barriers for remote clinicians, particularly across different jurisdictions. Tehnaz highlighted ongoing research into streamlining these barriers and developing AI tools to enhance telehealth capabilities, including potential applications for pediatric patients. The group expressed interest in having Tehnaz and Jerone return for future discussions about disaster response and telemedicine deployment. Wrap up and updates The team went through contact information and the team encouraged listeners to stay safe. The group discussed the role of specialized training, with Jamie highlighting the sponsorship of the Disaster Podcast by Paragon Medical Education Group. Catch the full episode using the player above or on your favorite podcast platform, and don't forget to subscribe to the Disaster Podcast for weekly insights from leaders in disaster response and research!

This week on Pulse: Amplify, Louise and George sit down with Pritesh Mistry, Fellow for Digital Technologies at The King's Fund, to dig into his provocative analysis Is the NHS Ready for the AI-Powered Patient?Pritesh argues the NHS is no longer the centre of a person's health experience, but one participant in a much larger ecosystem - and he unpacks the three forces driving that shift: direct-to-consumer innovation, generational change, and a growing role for employers. Pritesh asks if ‘NHS exceptionalism', the belief that any care delivered outside the NHS must be re-validated within it, is responsible in an era of resource constraint. Pritesh, Louise and George explore what it really takes to share authority and clinical risk with better-informed patients, the sycophancy problem with consumer AI, and whether these tools will widen or narrow inequalities. Pritesh makes the case for building "AI readiness" as a core public capability rather than hardwiring rigid plans.Connect with Pritesh on LinkedInResources:Pritesh Mistry, Is the NHS Ready for the AI-Powered Patient?, The King's Fund (26 May 2026) LinkKeep Britain Working Review: Final Report, GOV.UK LinkFit for the Future: 10 Year Health Plan for England, GOV.UK LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material. People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn Louise | George | Pulse+ITFollow us on BlueSky Louise | George | Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Back by popular demand, 3x Heart of Healthcare guest Eric Larsen joins Steve to answer listener questions on healthcare's AI revolution. Drawing on the ideas behind his latest essay, Healthcare's Oppenheimer Moment, Eric argues that healthcare may be approaching a once-in-a-generation inflection point, and discusses what leaders need to understand before it's too late.We cover:Whether foundation models will eventually outperform healthcare-specific AI companiesWhy healthcare remains stuck in AI pilot projects while the technology races aheadThe biggest obstacle to clinical AI adoptionWhy liability may be the most important (and least discussed) issue in healthcare AIEric's controversial take on how AI will reshape the healthcare workforce—Links:Eric's essay is available here —

In this episode of Medsider Radio, we sat down with Eric Kau, co-founder and CEO of Climatic.Climatic is commercializing L Max, a daily inhaled system that proactively supports lung function.Before Climatic, Eric served as COO of Seed Health and was part of the foundational team at Chewy. Earlier in his career, Eric held growth and operational leadership roles across consumer, wellness, and e-commerce businesses, including Amazon, BoxyCharm, Target, and Best Buy. In this interview, Eric discusses what it takes to build a consumer category that doesn't yet exist, how Climatic approached clinical validation and consumer education simultaneously, and how early user behavior helped identify the company's strongest initial customer cohorts.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Eric Kau, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:49) - Eric's path through Amazon, Chewy, Seed, and the consumer health experiences that led to Climatic (05:49) - Why Climatic is treating lung health like hydration, sleep, or nutrition (11:47) - How Climatic rapidly iterated on formulas, delivery systems, and prototypes to launch a product for a new category in under 2 years (14:56) - Climatic's approach to product design, which is built around gym bags, vanities, and existing wellness routines (19:59) - How early users shaped both Climatic's clinical strategy and its go-to-market focus on endurance athletes and biohackers (23:56) - Why Climatic spent more time teaching consumers about lung health than selling the product itself (34:07) - What investors needed to believe before funding a category that didn't yet exist (40:27) - How Climatic built a 15,000-person waitlist through Strava run clubs instead of paid ads

Why Medtech Commercial Strategies Stall and How to Fix Them One of the most common and costly mistakes in medtech commercialization is confusing clinical buy-in with commercial buy-in. A surgeon who loves your device, peer-reviewed data supporting it, and a field rep with a 20-year relationship can all be in place, and the deal can still stall out completely. Why? Because the doctor is not the buyer. On this episode host Adam Turinas sits down with Todd Laderach, a medtech commercial strategy veteran with over two decades of experience across sales, marketing, and go-to-market leadership. Todd now runs his own firm helping device companies get life-saving products off the shelf and into the hands of clinicians, and he brings a clarity to the commercial realities of medical device selling that I think will resonate well beyond the device world. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Most people are already asking AI about their health. Almost none of them believe the answers. Around 40% use it to make wellness choices, but fewer than 5% trust what it says. Matt Watson and Josh Anthony, CEO of Nlumn, dig into why.Josh has spent 25 years in food and nutrition, and his take is blunt: trust drops fast as the question gets serious, from a recipe to a diagnosis, and the fix isn't a smarter chatbot. It's pairing the data with a human people actually trust. They cover what's real right now too. The protein obsession. Beans having a moment. GLP-1s and why weight loss is now about saving muscle, not just dropping fat. Why people are building their own messy personalization stacks because no single company does it well.Matt also explains why he flat out ignores his doctors on cholesterol, and he and Josh go a few rounds on whether ultra-processed food is the problem or a missed opportunity.If you build or invest in health products, listen now. And if you want help with personalized nutrition, reach Josh@nlumn.com or info@nlumn.com.⏱️ Episode Breakdown00:28 Introduction to Health Tech and AI03:36 Trust in AI for Health and Nutrition06:29 Personalization in Health and Nutrition09:26 Emerging Trends in Health Tech12:23 The Role of GLP-1 in Weight Management15:29 Challenges in the Food Industry18:37 Innovative Products in Health and NutritionLinks & ResourcesConnect with Joshua Anthony on LinkedInNlumn Website - https://www.nlumn.com/Email - mailto: info@nlumn.comWhat Smart CTOs Are Doing Differently With Offshore Teams in 2025Subscribe to the Global Talent SprintFull Scale – Build your dev team quickly and affordablyIf you're trying to get your team out of the basement and into real product ownership, this episode is your playbook. Stop being a ticket factory. Build teams that think, create, and lead.

This week on Pulse: Hot Topics, Louise and George race through a very AI-heavy fortnight — from antibiotics and the menstrual cycle to whether "medical AI" is even a category worth defending.AI and Science. A Nature feature on AI accelerating antibiotic discovery (millions of molecules screened in silico, though only a tiny fraction can actually be synthesised), paired with a UK Biobank study mapping 198 proteins that fluctuate across the menstrual cycle — reframing it as a whole-body biological rhythm, not just a reproductive one.Do We Even Need Medical AI? A NYU study finds frontier general models outperforming purpose-built clinical tools like OpenEvidence and UpToDate — with an important caveat that no patient outcomes were measured. Paired with Apollo, Harvard's foundation model trained on 25 billion clinical events to forecast individual patient trajectories.What If AI Makes Healthcare More Expensive? David Brailer argues in Health Affairs that AI won't lower US health costs because it amplifies the incentives already baked into the payment system — accelerating both better care and billing extraction.The AI Equity Divide. A WHO-led initiative (GI-AI4H) and its RISE framework tackle the risk that AI widens global health inequities when governance lags behind deployment.Governing AI — Local and Professional. Victoria's Department of Health sets top-down standards for AI across public health services, while the American Medical Association champions "augmented intelligence" with clinicians at the centre — two very different models of governance.Plus: the robots now account for 57% of internet traffic, and a shout-out to Daniel McCabe's impact on Australian digital health.Resources:AI is taking on antibiotic resistance Link Plasma proteomic signature of the menstrual cycle LinkGeneralist vs clinical LLMs (OpenEvidence, UpToDate) — NYU study (Vishwanath, Oermann et al.) Link APOLLO healthcare foundation model LinkWhy AI Will Accelerate Health Care Inflation — David Brailer, Health Affairs LinkGlobal Initiative on AI for Health (GI-AI4H) and the RISE framework — npj Health Systems LinkAI guidance for Victorian Public Health Services — Pulse+IT LinkAugmented Intelligence in Medicine — American Medical Association LinkIda Tin — global challenge on continuous hormone monitoring LinkVisit Pulse+IT.news to subscribe to breaking digital news, weekly newsletters and a rich treasure trove of archival material.  People in the know, get their news from Pulse+IT – Your leading voice in digital health news.Follow us on LinkedIn  Louise  |  George  |  Pulse+ITFollow us on BlueSky   Louise  |  George  |  Pulse+ITSend us your questions pulsepod@pulseit.newsProduction by Octopod Productions | Ivan Juric

Dr. Jason Wersland turned a 3 a.m. garage experiment into the number one percussive therapy brand in the world, with more than 6.5 million Theragun massage devices sold. In this episode, he breaks down the unglamorous eight-year grind behind that overnight success: five prototypes, three bad partners, and a one-to-one credibility-building strategy that eventually landed him in Cristiano Ronaldo''s training room. For more on Therabody and show notes click here   Subscribe and watch Shopify Masters on YouTube!Sign up for your FREE Shopify Trial here.

Healthcare AI funding is booming, but the money is flowing to fewer companies than ever before. As investors pour capital into a small group of breakout winners, founders are navigating a fundraising environment where expectations seem to change every quarter. Based on interviews with 24 healthcare founders and a dozen healthcare investors, Halle breaks down what is actually happening in the market today, from pitch meetings and diligence processes to the growing debate over whether AI has fundamentally changed venture capital itself. Why healthcare AI fundraising has become a tale of two marketsThe two questions dominating investor meetings in 2026The metrics VCs are looking for todayThe debate over whether investors should abandon traditional ownership targetsWhy high valuations can be both a gift and a trap for founders —Show notes:Submit questions for our Eric Larsen healthcare AI Q&A here Part I: AI ate digital health (and what that means for fundraising)Part II: Convicted or disciplined: How healthcare VCs are split on investing—

In this episode, I'm joined by Max, co-founder of Superpower, a longevity and preventive health company based in San Francisco. Max shares his unconventional journey from a curious, entrepreneurial kid in Sydney to building one of health tech's most ambitious startups — all without a clinical background. He offers a refreshingly direct perspective on why clinicians are uniquely positioned to drive change in healthcare, why sunk cost is a trap, and why the best time to make your move is now. If you're a healthcare professional thinking about stepping into health tech, this episode will challenge the way you think about your career.Quotes:"Health professionals are some of the best placed to actually create change in health." - Max"Servicing a system allows you to impact maybe a few hundred or thousand people. Building a system ideally gets to the millions over time." - Max"The fastest path between A and Z is not to go through B, C, D — just do the thing." - Max"Being willing to be dumb is almost a prerequisite to being smart." - Max"If you're trying to do something in a new way, it's very hard to do that from the model of thinking that created the existing way." - MaxShow Notes:Why clinicians have an unfair advantage when building in health techHow to stop letting sunk cost hold you back from a career pivotThe difference between servicing the healthcare system and building itWhy the "one day I'll do this" mindset is keeping you stuckHow an outsider perspective can be the most powerful tool for reinventing healthcareLinks: https://www.matchday.health/ https://superpower.com/ https://www.linkedin.com/in/maxmarchione/

This episode of Quality Matters examines the growing role of digital wellness and chronic condition management programs and the challenge of measuring what truly matters. Host Rachel Harrington is joined by Peter Robertson of the Purchasing Business Group on Health and California Quality Collaborative and Kevin Masci of Omada Health to discuss how digital health solutions can help address rising healthcare costs, workforce shortages and fragmented care experiences. Peter and Kevin explain why meaningful engagement goes far beyond app downloads and login counts. Instead, successful programs focus on sustained participation, patient-centered goal setting, integration with primary care and measurable improvements in health outcomes. The conversation explores how employers, health plans and providers are evaluating digital solutions through clinical outcomes, patient-reported outcomes, utilization measures and value-based contracting arrangements. The guests also discuss one of the most important challenges facing digital health: trust. Privacy, transparency, data security and clear communication about how patient data is collected and used all play critical roles in long-term adoption. The episode concludes with a Patient Voice segment featuring Brandee Hicks, who shares her firsthand experiences using digital health tools, highlighting both the convenience they offer and the ongoing challenges around interoperability, digital literacy and maintaining support after programs end.     Highlights Beyond Logins and Clicks Meaningful engagement isn't about how often patients open an app. It's about helping people achieve their health goals through sustained participation and measurable outcomes. Measuring What Matters Guests discuss the growing use of clinical outcomes, patient-reported outcomes, utilization data and value-based contracting to assess digital health program performance. Trust Is Essential Digital health solutions must address concerns around privacy, transparency, data security and how patient information is stored and shared. The Patient Perspective Brandee Hicks shares how digital tools can improve organization, access and self-management while also revealing gaps in continuity, support and interoperability. Looking Ahead The future of digital health depends on better integration with primary care, more personalized engagement strategies and stronger measurement frameworks that prioritize patient outcomes.     Key Quote: "If we're really serious about improving health outcomes, we have to move beyond measuring clicks and logins. The real question is whether people are achieving meaningful progress toward their health goals—and whether these programs are creating lasting value for patients, providers and purchasers alike." — Kevin Masci     Time Stamps: (02:20) Meet Peter Robertson (03:45) Meet Kevin Masci (05:53) Why Digital Solutions Matter (10:01) Care Coordination, Not Care Fragmentation (11:52) Defining Meaningful Patient Engagement (15:07) Why Consistent Measurement Matters (18:32) Measuring Outcomes in Value-Based Contracts (21:12) Data Stratification, Risk Adjustment and Performance Guarantees (27:22) Privacy, Trust and Transparency in Digital Health (30:44) The Future of Digital Wellness and Chronic Care Management (35:08) Patient Voice: Brandee Hicks (40:25) Patient Challenges, Access and Continuity of Care (45:23) Key Takeaways and Closing Thoughts     Dive Deeper: Connect with Peter Robertson Connect with Kevin Masci Connect with Brandee Hicks Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

What does it really take to thrive as a first-time fund manager in today's challenging investment landscape, especially when you're building a venture fund from scratch while championing diversity and innovation? This episode delves into the real experiences behind the headlines, inviting listeners to consider the often unseen hurdles and triumphs that define entrepreneurial journeys. Our guest, Laurel Mintz, is the founder of Fabric VC—a new venture capital fund spun out of her extensive 17-year run as the leader of a successful marketing agency. With a background that includes corporate M&A law, entrepreneurship, and marketing, Laurel Mintz brings a unique and practical perspective to the venture capital world. Her approach blends deep sector knowledge with a commitment to supporting underrepresented founders and championing women's health, fintech, and consumer tech sectors. In this update, listeners get an inside look at the nuts and bolts of raising and deploying Fabric VC's first fund—just under $8 million, already largely deployed across 23 portfolio companies. Laurel Mintz shares candid insights on the emotional rollercoaster of fundraising, the critical importance of diversity, and the creative approaches to supporting women-led companies, such as accepting investments via donor-advised funds and retirement accounts. This episode is a must-listen for aspiring investors, founders, or anyone interested in how real change is being made within venture capital. It's raw, motivating, and packed with unfiltered advice on how to show up, take risks, and put capital to work for the next generation.   To get the latest from Laurel Mintz, you can follow her below! LinkedIn - https://www.linkedin.com/in/laurel-mintz/ https://www.fabricvc.com/ Laurel's first appearance on The Angel Next Door    Sign up for Marcia's newsletter to receive tips and the latest on Angel Investing! Website: www.marciadawood.com Learn more about the documentary Show Her the Money: www.showherthemoneymovie.com And don't forget to follow us wherever you are! Apple Podcasts: https://pod.link/1586445642.apple Spotify: https://pod.link/1586445642.spotify LinkedIn: https://www.linkedin.com/company/angel-next-door-podcast/ Instagram: https://www.instagram.com/theangelnextdoorpodcast/ TikTok: https://www.tiktok.com/@marciadawood

Episode 78 - Demi Radeva is CEO and Chief Strategist at Akros Advisory, where she helps digital health companies bring new products to market and accelerate growth.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

Autonomous vehicles may be the closest real-world example of AI operating in life-and-death situations at scale. Justin Norden believes healthcare has a lot to learn from how that industry approached safety, testing, adoption, and trust. This week, Michael and Halle sit down with the founder and CEO of Qualified Health, fresh off the company's $125 million Series B, to discuss why healthcare organizations need to think differently about deploying AI. Justin shares how his experience at Stanford, Apple, Waymo, and in healthcare investing shaped his view that health systems need AI infrastructure, governance, and workforce buy-in, not just another point solution.We cover:What healthcare can learn from Waymo's approach to safe AI deploymentWhat founders need to understand about building around EpicWhy health systems need to treat AI as a CEO-level priority, not an innovation projectHow Qualified Health is helping systems deploy, monitor, and measure AI workflowsWhy governance, safety, and ROI matter as much as model performanceWhy clinicians are right to be skeptical about AI liabilityAbout our guest:Justin Norden, MD is Co-Founder and CEO of Qualified Health building the trusted platform for health system AI. Additionally, he has been an Adjunct Professor at Stanford Medicine in the Department of Biomedical Informatics Research where his research and teaching focused on AI in medicine and digital health where he founded and still teaches courses on digital health and generative AI in medicine. Previously, Dr. Norden was Co-Founder and CEO of Trustworthy AI, a company focused on algorithm safety and trust, which was acquired by Waymo (Google Self-Driving). He was a Partner at GSR Ventures leading investments in healthcare and AI, worked on the healthcare team at Apple, and helped start the Stanford Center for Digital Health. Dr. Justin Norden received an MD and MBA from Stanford University, an MPhil in Computational Biology from the University of Cambridge, and a BA in Computer Science from Carleton College.—

Quiet Courage of the CMO There is a version of the marketing leader's job that looks great on a slide deck, and then there is the real thing. On this episode, we wanted to get at the real thing. Host Adam Turinas sat down with two marketing leaders who are currently in the middle of major company transformations, Erik Johnson, VP of Marketing at Harmony Healthcare IT, and Steffany Whiting, EVP of Marketing at iMethods. They are talking rebrands, ABM programs built from scratch, website overhauls, and bold calls about where to focus and where to pull back. The stakes are real for both of them. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Kara Egan, founder and CEO of Teal Health.Teal Health is the company behind the first FDA-authorized at-home cervical cancer screening wand.Before founding Teal, Kara worked in healthcare and software investing at .406 Ventures and Emergence Capital, and held product and marketing roles at Zendesk and Stitch Labs.  In this interview, Kara discusses building support and follow-up into at-home screening, how Teal expanded its comparative clinical study to support broader market adoption, and how healthcare incentives, reimbursement, and institutional trust shape new care models.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Kara Egan, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(02:49) - Kara's background in health technology investing and software that shaped Teal's consumer-first approach (05:14) - How Teal turned the traditional Pap smear into the first FDA-authorized at-home screening product (07:30) - Turning at-home testing, telehealth, and clinician follow-up into a single care experience (13:48) - Raising Teal's first $1M with mockups and consumer-grade design (22:17) - Teal's comparative study that matched physician-collected screening with 96% sensitivity (23:40) - How asking women what they actually wanted changed Teal's view of the market opportunity (32:05) - “Take off the healthcare hat” — Kara's framework for fundraising, incentives, and commercialization (41:48) - What investors actually care about beyond the company's mission

Healthcare is simultaneously propping up the US economy and facing one of its most uncertain moments in years.This month, Halle and Steve unpack the growing contradictions shaping digital health right now: healthcare jobs are driving nearly half of US job growth while provider bankruptcies surge, AI is flooding into healthcare faster than regulators can keep up, and Washington continues to send mixed signals on the future of healthcare policy and innovation.We cover:Why healthcare jobs are now carrying the US labor market and what Medicaid cuts could mean for the economyThe surprising comeback of wearables and how companies like Whoop, Oura, and Google are building massive subscription businessesCMS's new ACCESS model and the debate over whether AI-driven care can actually lower costs without sacrificing qualityThe lawsuit against Character.AI and what it reveals about the growing demand for AI mental health toolsWhy investors are pouring billions into AI drug discovery despite huge unanswered questions about clinical developmentMarty Makary's resignation from the FDA and what ongoing instability means for biotech, pharma, and healthcare innovation—Show notes:Forget Tech and Hollywood. California Is Powered by Healthcare Jobs. (WSJ)Oura Debuts Ring 5, Ahead of Potential IPO (WWD)Whoop Raises $575 Million at $10.1 Billion Valuation (Whoop)Fitbit Ditches the Screen With Its New $99 Whoop Rival (PC Mag)Why big digital health players are missing from Medicare's chronic care experiment (STAT)Character.AI Lawsuit (PA.gov) Marty Makary out as FDA chief (Axios)—

How to Build a Marketing Team That People Don't Want to Leave On this episode host Adam Turinas sits down with Larry Kaiser, Chief Marketing Officer at Optimum Healthcare IT, for a candid conversation about what it really takes to build a marketing team that lasts. Larry has spent nearly a decade growing the marketing function at Optimum from a logo and an outdated Drupal website into a tight, high-performing team. The lessons he has picked up along the way are ones that any marketing leader in healthtech will recognize. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

In this episode of Medsider Radio, we sat down with Karthik Ganesh, CEO of OnMed.OnMed is the healthcare technology company behind OnMed CareStation, a “Clinic-in-a-Box” designed to expand access to primary and urgent care. Before OnMed, Karthik served as CEO of EmpiRx Health, leading the company through rapid growth and a successful private equity transaction in 2021. Throughout his career, he's held leadership roles at QualCare, CareAllies, and Aetna, and advised healthcare organizations through Deloitte and EY.In this interview, Karthik discusses why hybrid care models still require a human touch, how enterprise healthcare buyers evaluate value propositions differently, why brand and culture should shape execution early, and how operating under constraints can sharpen innovation.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Karthik Ganesh, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - Karthik's obsession with healthcare access, and the “broken doorway” problem behind OnMed (05:51) - How OnMed combines telemedicine and brick-and-mortar care into a “Clinic in a Box” (09:04) - The OnMed metrics that surprised Karthik most, including a 37% patient return rate, and the reasons behind the company's success (09:22) - What OnMed designed differently after realizing that patients approach healthcare with their guard up (15:27) - The pitfalls of B2C healthcare and how OnMed was built as a B2B company by intention (22:01) - How Karthik reshaped OnMed around clarity, structure, and high performers (30:23) - What “brand” actually means to Karthik (39:37) - How OnMed tailored its value proposition for payers, providers, employers, and universities (45:45) - Karthik's fundraising philosophy: constraints keep companies inventive

Behavioral Health is Under Pressure, and Healthtech is Here to Help On this episode of In Practice, Dr. Robert Murry, chief medical officer at NextGen Healthcare, is joined by Javier Favela, vice president of market and segment strategy at NextGen Healthcare, and Erin Paige, solutions engineer at NextGen Healthcare and a licensed associate counselor, for a timely conversation on the pressures facing behavioral health organizations today. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Health Affairs Publishing's Jeff Byers welcomes Andrew Rundle of the Columbia University Mailman School of Public Health to the pod to discuss his recent Forefront article about Medicare's upcoming ACCESS model and its potential to expand digital health for chronic disease management. They discuss why the program could spur rapid growth in health tech while highlighting key challenges, including serving an older population with varying degrees of digital literacy and adapting to a new, evidence-driven marketplace. Related Links:The ACCESS Model May Set Off A Health Tech Gold Rush, But New Markets Bring Serious Obstacles (Health Affairs Forefront)A deeper dive into the ACCESS Model—Who's participating, potential headwinds and how it could spur health plan adoption (Fierce Healthcare)ACCESS (Advancing Chronic Care with Effective, Scalable Solutions) Model (CMS)ACCESS Model Accepted Applicants (CMS)Sign up for Health Affairs' free newsletter to catch up on our new articles, podcasts, and events.

Doctors are using ChatGPT in clinic right now — and some of them don't care about privacy. Three operators on what that means for healthcare AI. Recorded live at health.tech in Basel, this panel from Faces of Digital Health unpacks the convergence reshaping clinical software: ambient AI scribes, agentic AI in healthcare, on-device LLMs, and the regulatory drag (MDR, EU AI Act, EHDS) that is widening the gap between what clinicians actually use and what hospitals are allowed to buy. Host Tjaša Zajc is joined by: Jonathan Bringas — CEO & Founder, Lapsi Health (Kaiku: FDA-cleared AI stethoscope, ambient scribe and clinical assistant in one device) Blaž Triglav — CEO, Mediately (drug information platform, 1M+ HCPs across Europe) Amanda Herbrand — Clinical data modelling consultant, formerly University Hospital Basel What the conversation covers: — Why EHR data fragmentation is the precondition AI hasn't solved — Shadow AI: why clinicians trust ChatGPT more than enterprise tools (and the agency hypothesis behind it) — The convergence of stethoscopes, scribes, drug information and decision support into one workflow layer — ROI in healthcare AI: financial, time, clinical accuracy — and Herbrand's fourth dimension, user satisfaction — "Doctors were the original vibe coders": the 2,000 Excel spreadsheets running European hospitals — Why FDA-cleared beats MDR in 2026 sales cycles, and what Chile's regulatory minimalism tells us — The asymmetry that will break European medtech: applicants using AI to build, regulators forbidden from using AI to assess — On-device AI, ambient computing, AGI in clinical workflows — and the de-skilling risk no one wants to discuss ⏱ Chapters 00:00 — Opening: AI agents, vibe coding, and what doctors actually want 01:30 — Data fragmentation: the precondition AI hasn't solved (Amanda Herbrand) 02:30 — Keiku: collapsing stethoscope, scribe and assistant into one device 05:15 — The convergence reshaping healthcare AI — and the shadow AI in clinic 07:30 — Why doctors trust ChatGPT more than enterprise tools: the agency hypothesis 10:30 — ROI: financial, time, clinical accuracy — and Herbrand's fourth dimension 15:30 — Choosing solutions: modular requirements and FDA-cleared moats 19:30 — EHDS and the missing connector in European standardisation 21:00 — "Doctors were the original vibe coders": the 2,000 spreadsheet problem 24:30 — The two-speed world: regulated medicine vs the Wild West 28:00 — Why Chile's regulatory minimalism beats Europe's MDR 30:30 — Agentic AI vs regulators: the asymmetry that will break European medtech 33:30 — On-device AI, AGI, and the deskilling no one wants to discuss

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman, founder and CEO of Clairity.Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram.A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imaging Specialist at Massachusetts General Brigham (on leave). She holds an MD and PhD from Yale and was named to Forbes' 50 Over 50 Innovators and TIME 100 World's Most Influential Leaders in Health.In this interview, Connie discusses her experience translating academic research into a commercially viable startup, the massive undertaking of generating clinical evidence when you're creating a new category, and how Clairity is approaching adoption on two fronts: fitting into physician workflows and building access pathways for patients.Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device founders and CEOs and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.And if you're ready to level up your medtech game, you should check out Medsider Courses — 8-week masterclasses covering topics like fundraising, M&A and exit planning, design and development, clinical and regulatory strategy, and commercialization.These courses, featuring hard-earned lessons from elite medtech CEOs, can be purchased individually or come free with our All-Access Pass.If you'd rather read than listen, here's a link to the full interview with Connie Lehman, which includes a link to ScottBot — an AI version of host Scott Nelson trained on every Medsider interview and playbook. Feel free to ask ScottBot any questions you'd like!KEY MOMENTS FROM THE INTERVIEW(03:04) - The broken screening paradigm Connie saw in clinic — and the gap that became Clairity (05:09) - How Clairity rolls the clock back from detection to predicting risk in healthy women (07:31) - Why "more data is better" turned out to be wrong and how that shaped Clairity's product scope (21:57) - How physicians can translate grant-generating discipline into building a company (24:56) - What 18 months of pre-sub meetings revealed about navigating a de novo pathway (26:49) - Why Clairity validated its technology in over 250,000 mammograms when FDA required far less (34:43) - How Connie flipped the natural question from "how can doctors offer this?" to "how can women access it?" (43:47) - How relationships, not pitches, drove Clairity's $43M Series B

How much business are you losing simply because you're not staying in consistent contact with your audience? Most companies don't have a sales problem—they have a follow-up problem. And follow-up isn't about chasing people…it's about staying top of mind with value, relevance, and consistency. That's why my interview with Smita Wadhawan, CMO of Constant Contact, on the THINK Business – What Are You Good At? series hit on a hard truth—consistency is the new marketing advantage. Here are 5 takeaways that stood out: ✅ Mindshare → Market Share People can't buy from you if they forget you exist. Marketing isn't optional—it's oxygen. ✅ Consistency builds trust Trust isn't built in a moment—it's built in the follow-up moments people rarely do. ✅ Simple wins Customers don't want clever. They want clear. They want fast. They want relevant. ✅ Start now—then scale Stop overthinking platforms, funnels, or brand perfection. Start small. Ship. Learn. Improve. ✅ AI is here to help, not replace Use AI to automate repetitive work—so you can stay human where it matters most.   Smita Wadhawan Verma Global Chief Marketing Officer | Top 50 CMO | PayPal | Intuit | GoDaddy | Visa | SaaS | HealthTech | FinTech Award-winning Chief Marketing Officer with experience at GoDaddy, PayPal, Intuit, VISA, and SimplePractice — across SMB/consumer, SaaS, HealthTech, and FinTech. Global teams and global leadership at EcoVadis. Scaled and led businesses from a mid-size company to a $32B established brand, with budgets up to $175M. Expertise in growth marketing, product marketing, B2B and B2C marketing, lifecycle marketing, PR and comms. Smita has built and led teams of 150+ people in highly matrixed, cross-functional organizations across the US, Europe, Africa, Japan and India. She has partnered with top agencies like Koto, Instrument, Razorfish, TBWA, Highwire PR — and managed award-winning internal creative teams. Under Smita's leadership, her teams have won Digiday Awards and several Webby Award nominations. Smita is well known as a culture champion and recognized as a highly influential and inclusive C-Suite leader who can inspire teams to deliver outstanding results. Recognized as a 2024 Top 50 CMO in the US. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience Website: https://jondwoskin.comLinkedIn: https://www.linkedin.com/in/jondwoskin Email: jon@jondwoskin.com Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Jeff Gunsberg:Website: https://title-connect.com Connect with Smita Wadhawan:LinkedIn: https://www.linkedin.com/in/smitawadhawan/ *E - explicit language may be used in this podcast.

Most careers don't follow a straight line. But few require starting over in full view of the public.This week, Halle sits down with Lance Armstrong to discuss how he rebuilt his life and career after multiple turning points, including surviving advanced cancer, and how those experiences shaped his perspective on health, performance, and reinvention. Now, through his venture firm Next Ventures, he backs companies focused on what they call “whole person health” — spanning prevention, wellness, diagnostics, longevity, and healthcare outside the traditional system.We cover:Why he chose to become a VC, and what he likes (and dislikes) about the jobHow his experience as a patient shapes how he evaluates companiesWhy preventive care is growing outside the traditional healthcare systemWhat he looks for in founders building across the care continuumWhat it takes to rebuild trust and start overAbout our guest:Lance Armstrong is a former professional cyclist, entrepreneur, and investor. After surviving advanced testicular cancer, he founded Livestrong, helping raise more than $500 million to support cancer patients and survivors worldwide. In 2019, he co-founded Next Ventures, a venture capital firm focused on health, wellness, and consumer brands, with investments including Oura, Cofertility, Pair Team, and SteadyMD. Prior to Next Ventures, he was an active angel investor in companies such as Uber, DocuSign, and Athletic Brewing.—

A Practical Guide to Intent-Driven ABM and AI in Healthtech This episode is the final installment in a three-part miniseries on ABM and go-to-market strategy, and it is extremely practical. Host Adam Turinas is joined by guest Rehan Mirza, Chief Growth Officer at Verifiable, a credentialing automation platform that has lived through every stage of the ABM journey, from cold outbound blasting to sophisticated, intent-driven orchestration across a complex enterprise sales motion. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

Episode 77 - Sam Fay, CEO of SISU Health, is leading the mission to make preventative health more accessible. With 25 years' leadership experience, she has a proven track record in scaling organisations and driving measurable impact.Disclaimer: Please note that all information and content on the UK Health Radio Network, all its radio broadcasts and podcasts are provided by the authors, producers, presenters and companies themselves and is only intended as additional information to your general knowledge. As a service to our listeners/readers our programs/content are for general information and entertainment only.  The UK Health Radio Network does not recommend, endorse, or object to the views, products or topics expressed or discussed by show hosts or their guests, authors and interviewees.  We suggest you always consult with your own professional – personal, medical, financial or legal advisor. So please do not delay or disregard any professional – personal, medical, financial or legal advice received due to something you have heard or read on the UK Health Radio Network.

AI in healthcare may be entering a new chapter, one where the biggest question is no longer whether the technology works, but who is willing to deploy it, measure it, and take responsibility for the risk.This week, Steve sits down again with Eric Larsen to revisit his predictions from last year's Webby-winning episode on generative AI in healthcare. Eric argues that the first wave of AI has been inflationary, reinforcing the old payer-provider payment model, but that the next wave could be deflationary as automation moves into revenue cycle, administrative work, clinical reasoning, and drug development. They discuss why incumbents still have a narrow window to co-develop the future, why clinical AI may move faster outside the US, and why liability may become the deciding factor in who wins.We cover:Why healthcare is still the sector most exposed to AI-driven changeHow AI has reinforced fee-for-service dynamics so far, and why that may soon reverseWhat makes some healthcare work more automatable than othersWhy liability may determine how fast clinical AI gets adoptedWhich health systems, payers, and life sciences companies are moving fastestWhat will change across providers, payers, and pharma over the next year—

What does the senior CMS official focused on payment and delivery innovation actually want health tech founders to understand? In this episode, we listen in on highlights from a recent fireside chat as StartUp Health co-founder Unity Stoakes talks with...

Betsy Kauffman is a globally recognized executive leadership coach and organizational agility consultant with over 25 years of experience transforming Fortune 500 leadership teams into high-performing, aligned powerhouses. As Founder and CEO of Cross Impact Coaching, she partners with CEOs and their executive teams—primarily in HealthTech and FinTech—to align strategy, execution, and team dynamics for lasting results. Her signature Leadership Alignment Lab blends executive coaching, proprietary 360 feedback, and strategic offsites to help C-suites turn vision into action. She also co-owns Kauffman & Co. Furniture, giving her a unique perspective on scaling and leading both service- and product-based businesses.